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Abstract: 
The objective of this research was to evaluate the impact of Integrated Assertive Community 
Treatment (I-ACT) on psychiatric symptoms, drug use, housing status, and service utilization. A 
single-group repeated measures evaluation of outcome indicators at intake, 6 months, and 12 
months examined changes over time with 555 respondents receiving outpatient treatment. While 
555 received baseline interviews, figures vary on follow-up sample sizes and are listed as they 
are discussed in the paper. The study was implemented by a community treatment provider. The 
primary analyses used in this study were repeated measures ANOVA and the Friedman's two-
way analysis test. Significant reductions in substance use (F(1.69, 553.02) = 94.30, p < .01) and 
psychiatric symptoms (F(1.98, 299.19) = 43.73, p = .0001) were found from baseline to 6 months 
and changes were sustained from the 6- to 12-month follow-up points. Similar results were found 
in housing status with the number of participants in stable housing rising significantly. 
Utilization of substance use and psychiatric treatment declined significantly across all three 
follow-up points, and physical health service use remained unchanged. I-ACT has demonstrated 
efficacy through controlled research studies, and this evaluation extends on these findings to 
demonstrate that I-ACT is effective in community service provision settings in reducing 
substance use and psychiatric symptoms. Further, the reduction in service use found across 
follow-up points indicates cost containment. 
Keywords: Substance use | co-occurring disorders | assertive community treatment | integrated 
treatment 
Article: 
Rates of co-occurring substance abuse and mental illness are presently high (Regier et al., 
1990;Mueser, Noordsy, Drake, & Fox, 2003) and expected to double in the United States from 7 
million to 10 million (U.S. Department of Health and Human Services, 2003) to 15 million in 30 
years (New Freedom Commission on Mental Health, 2003). While the prevalence of co-
occurring disorders grows, the current treatment system is not structured to meet the needs of this 
population. The National Survey on Drug Use and Health (Substance Abuse and Mental Health 
Services Administration [SAMHSA], 2008) illustrates this mismatch of co-occurrence to two 
treatment systems that operate in parallel to one another as opposed to an integrated system of 
care. An estimated 24.3 million adults aged 18 or older experienced serious psychological 
distress (SPD) within the past 12 months. Of those with SPD, 10.8 million (44.6%) reported 
receiving some form of mental health treatment within the same period, and 5.4 million reported 
a dependency on alcohol or illicit drugs. Among the 5.4 million reporting a co-occurring SPD 
and substance use disorder, 33.3% received mental health treatment only compared to 2.8% 
receiving only substance use treatment. More importantly, 10.4% received both mental health 
and substance use treatment concurrently, while 53.7% received no treatment for either. Only 1 
in 10 persons with a co-occurring disorder receives treatment for both mental illness and 
substance abuse (SAMHSA, 2008). 
Due to the parallel systems to treat mental illness and substance abuse, clinicians treating these 
disorders are faced with the dilemma of where to focus treatment. To address this, SAMHSA 
(2009) currently endorses an integrated treatment model for co-occurring disorders that provides 
a unified and comprehensive program that is delivered through a multidisciplinary team that has 
received specialized training in co-occurring disorders. Critical components of an integrated 
program can include assertive outreach; comprehensive assessment; motivational and staged 
interventions; risk reduction; tailored mental health and substance abuse treatment/counseling; 
social support interventions; a long-term perspective of remission and recovery; and cultural 
sensitivity and competence (Minkoff, 1991; Drake et al., 2001; Drake, Mercer-McFadden, 
Mueser, McHugo, & Bond, 1998). Ideally, integrated programs combine and build upon existing 
programs wherever possible. Despite federal and local government awareness, many community-
based service providers lack the range of services, specialized staffing resources, and funding to 
offer a continuum of care approach, which is embedded in an integrated treatment approach. 
To address the problematic treatment environment described above, Foundations Associates 
(FA) created an integrated treatment program for persons with substance abuse disorders and 
severe and persistent mental illness. Because of the severity of mental illness faced by the clients 
served by FA, Assertive Community Treatment (ACT) was delivered through an existing 
integrated treatment model. This approach allowed for simultaneous treatment of substance 
abuse and mental illness as well as intensive open-ended services for the severe and persistent 
mental illness faced by FA clients that ACT provides. 
ACT was developed approximately 30 years ago as mental health care was undergoing radical 
changes in the United States. Inpatient treatment for the mentally ill was being eschewed for 
community-based treatments during the deinstitutionalization of the 1960s. ACT was developed 
to meet the needs of severely mentally ill consumers in the community. In the years since ACT 
was developed, it has been evaluated with a wide range of consumers including homeless 
persons (Coldwell & Bender, 2007;Lehman et al., 1999; Lehman, Dixon, Kernan, Deforge, & 
Postrado, 1997; Meisler, Blankertz, Santos, & McKay, 1997), mentally ill persons involved in 
the criminal justice system (Cosden, Ellens, Schnell, & Yamini-Diouf, 2005;Cosden, Ellens, 
Schnell, Yamini-Diouf, & Wolfe, 2003; McCoy, Roberts, Hanrahan, Clay, & Luchins, 
2004; Meisler et al., 1997), and persons with co-occurring mental illness and substance use 
disorders (Drake, McHugo et al., 1998; Meisler et al., 1997). Additionally, studies have been 
conducted to determine ACT's impact on housing stability (Drake, Yovetich, Bebout, Harris, & 
McHugo, 1997; Lehman et al., 1997; Meisler et al., 1997), homeless persons with co-occurring 
mental health and substance use disorders (Young, Clark, Moore, & Barrett, 2009), mental 
illness symptom reduction (Coldwell & Bender, 2007; Cosden et al., 2005; Lehman et al., 1997), 
cost-effectiveness compared to traditional models (Essock, Frisman, & Kontos, 1998; Lehman et 
al., 1999), and drug and alcohol use (Cosden et al., 2005; Drake et al., 1998a,1998b). Across 
populations and variables, ACT has consistently performed as well as other models of care, and 
in many instances it has outperformed other approaches on one or more of the outcomes 
discussed above. 
BACKGROUND 
In 2000, SAMHSA designated FA, located in Nashville, Tennessee, one of three exemplary 
program models in the United States for integrated treatment for co-occurring disorders. FA was 
featured at the Co-occurring Institute of the State System Development Program 5th Conference 
(SSDP V). FA's residential services were also selected as a finalist for the American Psychiatric 
Association's Gold Achievement Award (2000). FA participated in the National Dialogue on Co-
occurring Mental Health and Substance Abuse Disorders (National Association of State 
Alcohol/Drug Abuse Directors, 1998). As a result of this think tank effort, a conceptual 
framework requiring three levels of service coordination (a consultation ensuring that both 
psychiatric and substance problems are addressed; collaboration ensuring that both substance and 
psychiatric problems are included in the treatment regimen; and service integration that merges 
all treatment efforts) was later used as the foundation for SAMHSA's (2002) Report to Congress. 
FA's extensive involvement in providing services to persons with co-occurring disorders was 
further advanced by the addition of the ACT treatment model, hereafter referred to as I-ACT. 
Two studies have been conducted to date on Integrated ACT treatment (Drake, McHugo et al., 
1998; Essock et al., 2006). Both of these studies used standard case management (SCM) as a 
comparison group with the I-ACT intervention with populations experiencing both severe mental 
illness and substance abuse. Drake et al. had a total of 223 participants, while Essock et al. had 
198. Both studies found that the I-ACT groups had fewer actual hospitalizations and fewer mean 
days hospitalized than the SCM. Similarly, while both groups in both studies improved in terms 
of days in stable housing, the I-ACT groups in both studies showed significantly greater gains in 
stable housing days. No significant differences were found between I-ACT and SCM in either 
study in terms of psychiatric symptom reduction. Both studies did find that psychiatric symptoms 
were reduced. 
Drake et al. (1998a) found in their study that, while both groups showed improvements in 
substance use outcomes, the I-ACT group demonstrated greater gains on some metrics. 
Outcomes were similar for both groups in terms of substance use reduction, with the I-ACT 
showing more significant gains in the last year of the study. Significant differences were not 
found for drug or alcohol remission between groups. Essock et al. (2006) report similar findings. 
Participants reported more steady reductions in drug use among the I-ACT groups, while the 
SCM groups had greater reductions in alcohol use. 
SERVICE DELIVERY MODEL 
The general efficacy of ACT programs is well-documented in the research literature. 
Additionally, there is a substantial evidence for the use of an integrated treatment approach in 
treating persons with co-occurring disorders (Bride, MacMaster, & Webb, 2006). More research 
is needed on combined ACT and integrated treatment approaches for persons with co-occurring 
disorders. Toward addressing this gap in the I-ACT literature, this study will analyze the 
outcomes of an I-ACT intervention on housing, psychiatric symptoms, substance use, and 
service utilization of the participants in this study. 
The I-ACT model employed for this study paired derivate characteristics of ACT with key 
components of effective integrated treatment (i.e., assertive outreach, motivational enhancement, 
stage-wise approaches, counseling/support, and long-term and comprehensive interventions); the 
model integrated core competencies by developing a team with mental health and substance 
abuse training as well as expertise in housing, vocational rehabilitation, outreach, and peer 
support. Consistent with the ACT model, the team members included substance abuse 
counselors, a psychiatrist, a nurse practitioner and several case managers providing vocational 
rehabilitation, housing assistance, homeless outreach, and a consumer paraprofessional. Weekly 
and daily treatment teams were conducted to ensure a team approach to treatment. In addition to 
the ACT model, an existing outpatient co-occurring disorders treatment center provided 
individual and group mental health and substance abuse counseling. 
All team members maintained low caseloads and addressed consumer needs across clinical 
domains. Caseloads averaged 10 to 15 consumers per case manager in order to provide more 
intensive time-unlimited services and outreach efforts in the community. Outreach activities 
included initial engagement and ongoing reengagement contacts when necessary. The frequency 
of contacts and specific interventions utilized were based on individual needs. Most participants 
received more frequent case management contacts initially and then gradually reduced as 
symptoms improved and consumers became more stable. Reduced caseloads allowed the 
treatment team to deliver a comprehensive array of services, including psychopharmacologic 
treatments and monitoring, individual and group therapy, support groups, illness management 
and recovery skills, intervention with support networks (family, friends, neighbors, landlords), 
vocational training and support, along with assistance with activities of daily living, and a variety 
of support services (transportation, medical care, housing, and benefits). 
METHOD 
Design 
This study utilized a single-group design (aggregating program participants over the duration of 
the project), with repeated measures of program outcome indicators at program intake (baseline) 
and 6 months and 12 months post-intake to examine changes over time (Cook & Campbell, 
1979). The major strengths of the evaluation for establishing program effectiveness were (1) 
using program participants as their own controls with data from baseline and 6- and 12-month 
follow-up interviews (combined with data on their service use) and (2) basing the evaluation on a 
centralized management information system to allow program monitoring and outcome 
evaluation. 
Sample 
The modified ACT program enrolled 555 participants from March 2002 to January 2004. 
Approximately half were male, 62% were White and 37% were Black, and 68% were between 
26 and 45 years of age. Participants generally remained in programming for a full 12 months and 
beyond, although the engagement was frequently interrupted. Consumers would often stop 
showing up for services and not be able to be contacted and then show up again at a later date. 
Given this pattern of use, it is difficult to determine how long participants were actively engaged. 
To manage this irregular pattern, baseline interviews were conducted upon initial entry, and even 
after a period of absence consumers would be administered the follow-up interview (6 or 12 
months) based on the date of their baseline interview. 
Almost half of participants did not complete high school (42%), 27% reported full- or part-time 
work, and 56% reported less than $300 income in the last 30 days from all sources. Table 
1 depicts the above data graphically. Of this total baseline admission of 555, varying numbers of 
participants completed all three follow-up points with all the instruments. Interviewers were 
service staff and were focused on achieving the 80% Government Performance and Records Act 
(GPRA) follow-up rate, and when participants indicated that they did not want to complete 
follow-ups the worker would offer to do just the GPRA or start with the GPRA and allow the 
participant to stop when they wished. 
Table 1. Baseline Sociodemographic Characteristics of Sample 
Variable n 
Race White Black  
 n % n %  
 349 63.30 202 36.70 551 
Sex Male Female  
 n % n %  
 276 50.08 275 49.92 551 
Housing Street Shelter/Institution Housed  
 n % n % n %  
 61 11 308 55.44 186 33.56 555 
 M Min Max SD n 
Education 
(highest 
grade 
completed) 
11.61 6 17 2.14 552 
Total legal 
income in 
last 30 days 
$316.95 $0 $12,000.00 $729.53 549 
Nights in 
jail in last 
30 days 
2.20 0 30 6.91 554 
Number of 
arrests in 
last 30 days 
0.13 0 10 0.64 555 
Global 
Assessment 
of 
Functioning 
47.38 30 63 5.66 444 
Alcohol use 
to 
intoxication 
in last 30 
days 
5.44 0 30 8.99 555 
Illegal drug 
use in last 
30 days 
8.41 0 30 10.62 555 
        
To ensure equality of participants only receiving baseline administrations to those who received 
follow-up interviews, several analyses were run to determine any differences. Chi-square 
analyses were run comparing the race (χ2 = 4.52, p = .104), sex (χ2= 5.39, p = .067), housing 
status (χ2 = 2.11, p = .716), diagnoses of alcohol abuse (χ2 = 1.05, p = .591) or dependence (χ2 = 
1.21, p = .271) and drug abuse (χ2 = 9.28, p = .002) or dependence (χ2 = 10.00, p = .002) of those 
completing no follow-up to those completing one and both follow-up interviews. For these 
analyses, no significant differences were found except in the case of the drug and alcohol abuse 
and dependence measures. Participants who completed one follow-up interview were more likely 
to have an alcohol or drug use disorder diagnosed than those completing only the baseline. 
Further, those completing both follow-up interviews were even more likely to experience drug or 
alcohol abuse or dependence than those completing only one follow-up or baseline only 
interviews. 
To compare the psychiatric symptoms of participants completing baseline only to those 
completing one or both follow-up interviews, an ANOVA was run comparing the Brief 
Symptom Inventory (BSI) subscale scores. No significant differences were found on any of the 
subscales and the F scores and p values for each analysis are reported in Table 2. 
Table 2. BSI Comparisons: Baseline Only to One and Two Follow-Ups 
  Baseline 
Only n = 45 
One Follow-
Up n = 159 
Two Follow-
Ups n = 313 
ANOVA   
Subscale M SD M SD M SD F p Total N 
Somatization 1.33 0.96 1.23 0.97 1.27 0.90 0.266 .767 517 
Obsessive 
compulsive 
2.16 1.05 2.15 1.11 2.11 1.07 0.114 .892 517 
Interpersonal 
sensitivity 
1.91 1.16 1.91 1.20 1.96 1.11 0.117 .890 517 
Depression 2.22 0.97 2.11 1.17 2.15 1.12 0.162 .850 517 
Anxiety 2.13 0.99 2.07 1.12 1.92 1.05 1.565 .210 517 
Hostility 1.51 1.00 1.38 1.08 1.41 1.04 0.232 .793 517 
Phobic anxiety 1.50 1.05 1.39 1.08 1.33 1.01 0.518 .596 517 
Paranoid ideation 1.93 1.05 1.72 0.98 1.84 1.00 1.090 .336 517 
Psychoticism 2.04 1.07 1.80 1.05 1.82 0.98 0.997 .370 517 
Global Severity 
Index 
1.89 0.81 1.76 0.91 1.77 0.84 0.387 .679 517 
Positive 
symptom distress 
index 
2.47 0.63 2.37 0.73 2.33 0.67 0.953 .386 517 
Positive 
symptom total 
38.00 10.03 36.88 12.14 37.95 11.47 0.481 .619 517 
 
Illegal drug use was reported more frequently than alcohol use (57.8% compared to 49.4%), 
while cocaine use (42.1%) was more common than alcohol use to intoxication (39.2%). General 
quality of life domains indicated lowest satisfaction with finances, while health-related quality of 
life indicated poorer quality of life for mental health compared to physical health–related quality 
of life. 
Relative to BSI normative data for psychiatric outpatient consumers, program 
participants’ t scores tend to fall around the 60th to 70th percentile in psychiatric severity (i.e., 
the average participant in this study scores higher than 60% to 70% of typical psychiatric 
outpatients). This trend can be seen across all psychiatric domains, and although there is some 
fluctuation across domains, the global severity category indicates that the average of participants 
in this study report higher symptom severity than almost 75% of psychiatric outpatients and 
almost 99% of the general population. Figure 1compares the BSI scores of FA program 
participants to BSI outpatient norms and BSI census norms. 
 
Figure 1. Comparison of participants' BSI t scores to outpatient norms 
Inclusion Criteria 
All clients receiving services from the program were included in the study. In order to be 
included, participants must report having a diagnosed Axis I or II mental disorder and be 
assessed to have an abuse or dependence problem with alcohol or other drugs using the Triage 
Assessment for Addictive Disorders (TAAD) interview. Assessment of mental disorders were 
conducted by master's-level clinicians using a comprehensive psychosocial interview. The 
TAAD interview is designed to identify symptoms of a possible current DSM-IV diagnosis of 
abuse or of dependence for alcohol or other drugs. The TAAD assesses both dependence and 
abuse by establishing a pattern of behaviors or consequences rather than simply a pattern of use. 
The TAAD has 16 items that address drug dependence and 19 that address alcohol dependence. 
According to TAAD scoring procedures (Campbell, Hoffman, Madson, & Melchert, 2003), 
possible dependence is indicated if the individual endorses items from at least three of 
the Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) categories for 
dependence. A more stringent dependence criterion requires positive responses on at least five 
different dependence items. Similarly, possible abuse is indicated if the individual endorses at 
least one item in any of the four DSM-IV abuse categories, while the more stringent abuse 
criteria require at least two different indications of abuse in one or more of the categories. For 
our purposes, indications for abuse or dependence reflect the more stringent criteria. 
Procedures 
After enrolling in the project, trained intake staff explained to participants that the evaluation 
component of the project involved a baseline interview with follow-up interviews at 6 and 12 
months. Participants were assured that they could refuse to participate in the interviews and still 
receive services. Confidentiality procedures were explained and informed consent obtained. To 
facilitate follow-up interviews, extensive locator information was collected including alternate 
contacts (friends, family, or others). Institutional review board approval for research with human 
subjects was applied for and obtained through the dual diagnosis management institutional 
review board. 
Measures 
Consistent with previous research on ACT, the authors sought to examine changes in substance 
use, psychiatric symptoms, housing status, and utilization of services. The measures used to 
examine theses changes are described below. 
Substance Use. Substance use frequency is based on days of self-reported use in the last 30 days 
for alcohol use, alcohol use to intoxication (greater than four drinks), and other illegal drug use 
as captured by Addiction Severity Index items employed in the GPRA (Kosten, Rounsaville, & 
Kleber, 1983). Substance use abstinence is a dichotomous variable indicating any substance use 
in the past 3 months. 
Psychiatric Symptom Severity. The BSI (Derogatis, 1993) was used as an indicator of psychiatric 
severity. The BSI is a subset of the Symptom Checklist-90–Revised (with similar validity and 
reliability and a shorter administration time). The BSI contains 53 items corresponding to nine 
symptom dimensions: somatization, obsession-compulsion, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. Additionally, the BSI 
allows for the calculation of three global indices: a global symptom index, a positive symptom 
distress index, and a positive symptom total. The Global Assessment of Functioning, the fifth 
axis of the multiaxial diagnostic system used in the DSM IV-TR, was also used. 
Housing Status. Individuals’ housing status was measured with items from the GPRA that were 
again drawn from the Addiction Severity Index (Kosten et al., 1983). These items measure the 
number of days out of the past 30 days that the participant was homeless, housed, or in an 
institution. To create the categorical variable reported, participants’ responses were recoded to 
reflect the housing condition they experienced for the majority of the previous 30 days. 
Service Utilization. The Treatment Services Review (TSR) was developed to measure the 
amount of particular services persons in alcohol and drug treatment receive. The TSR-6, a 
revision of the original TSR that was designed to allow for collection of past-month service use, 
was used in this study (Cacciola et al., 2008). Initial study of the reliability and validity of this 
revision indicates acceptable test-retest reliability on the 28-day review period and discriminate 
validity comparable to the original TSR. 
Data Analysis 
Descriptive statistics were analyzed to characterize the study sample in terms of demographics, 
substance use, psychiatric severity, and housing status (see Table 1). These analyses provided a 
baseline description of the study sample from which changes over time could be assessed. 
Analyses of changes from baseline to 6 and 12 months on substance use outcomes were assessed 
using ANOVA techniques. The basic research design was a single-factor repeated measures 
ANOVA with three levels (baseline and 6-month and 12-month follow-up). Several variables 
were measured at the ordinal level, and in such cases the Friedman's two-way analysis by ranks 
test was used. The important analytic questions regarding program effectiveness involved the 
magnitude of changes from baseline on outcomes and the maintenance or stability of changes 
from baseline, at 6 months, and at 12 months. 
RESULTS 
Psychiatric Symptom Severity 
Severity of psychiatric symptoms was reduced significantly at the first follow-up point, and the 
reduction was maintained at 1-year follow-up. The means and results of the repeated measures 
ANOVA for each domain of psychiatric symptom are listed in Table 3. Analysis of the positive 
symptom total was conducted using the repeated measures ANOVA. The Huynh-Feldt correction 
was used (ϵ = .99). The findings indicate a significant effect on the number of psychiatric 
symptoms across categories experienced by participants at each follow-up point, F(1.98, 299.19) 
= 43.73, p = .0001. Similarly, the repeated measures ANOVA indicated a significant decline in 
problem symptom distress index scores at each follow-up point, F(2, 302) = 38.75, p = .0001). 
Table 3. Psychiatric Symptom Severity Outcome 
  Baseline 6 Months 12 Months ANOVA   
Outcome Measure M SD M SD M SD F p N 
Somatization 1.24 0.92 0.85 0.89 0.80 0.75 38.70 .0001 152 
Obsessive compulsive 2.08 1.03 1.48 1.11 1.39 1.10 49.95 .0001 152 
Interpersonal sensitivity 1.97 1.08 1.37 1.13 1.19 1.11 59.56 .0001 152 
Depression 2.10 1.13 1.45 1.11 1.28 1.09 63.03 .0001 152 
Anxiety 1.89 1.05 1.19 1.03 1.06 0.97 96.27 .0001 152 
Hostility 1.47 1.07 1.02 1.01 0.96 0.96 26.58 .0001 152 
Phobic anxiety 1.29 1.03 0.88 0.96 0.79 0.88 22.91 .0001 152 
Paranoid ideation 1.85 0.98 1.45 1.11 1.25 0.97 49.71 .0001 152 
Psychoticism 1.79 0.98 1.25 1.03 1.07 0.96 67.44 .0001 152 
Global Severity Index 1.76 0.84 1.22 0.88 1.09 0.83 82.68 .0001 152 
Positive symptom distress 
index 
2.32 0.69 1.92 0.74 1.83 0.79 53.74 .0001 152 
Positive symptom total 38.11 10.96 29.83 14.36 27.04 15.38 76.39 .0001 152 
Note. 152 participants completed all three follow-up administrations of the BSI. 
Housing Status 
Evidence of greater access to permanent housing arrangements following enrollment in the 
program were strongly supported by several housing outcome indicators. Almost 70% of 
participants were housed in their own or someone else's apartment room or house 12 months 
after enrollment compared to approximately 33.5% at baseline. The percentage living in a shelter 
or on the street decreased from 11% at baseline to 7% at 12 months following enrollment in the 
program. Those who indicated not having enough money for housing decreased from 60.2% at 
baseline to 32.8% at 12 months. 
Service Utilization 
The TSR was used to measure service utilization. Several measures of utilization are reported, 
including inpatient and outpatient physical health, mental health and substance abuse services, as 
well as emergency department services for physical and mental health and substance abuse. 
Findings for each are reported below; in addition, the findings for service use are reported 
in Table 4. 
Table 4.  Service Utilization 
  Baseline 6 Months 12 
Months 
ANOVA   
Outcome Measure M SD M SD M SD F p N 
Physical health service use 
(inpatient) 
0.33 2.65 0.03 0.24 0.02 0.25 1.85 .17 a 143 
Physical health service use 
(outpatient) 
0 0 0.19 0.93 0.14 0.96 2.26 .11 a 144 
Mental health service use 
(inpatient) 
2.27 5.80 0.84 2.77 0.57 3.03 8.06 .001 a 148 
Mental health service use 
(outpatient) 
0.60 1.76 4.47 7.17 2.57 6.42 19.06 .0001 a 158 
Mental health service use 
(emergency department) 
0.30 0.63 0.16 0.55 0.14 0.69 3.09 .05 a 147 
Inpatient substance abuse 
treatment 
1.42 4.95 0.62 2.31 0.26 1.68 4.68 .019 b 148 
Outpatient substance abuse 
treatment 
1.08 3.96 4.42 7.73 2.39 6.55 10.53 .0001 a 150 
aHunyh-Feldt correction; bGreenhouse-Geisser correction. 
Physical Health. Significant differences in the utilization of inpatient, outpatient, or emergency 
department physical health services were not found. While the mean number of visits in each 
service category did decline, they were not significant. 
Mental Health. Significant decreases in all mental health service utilization were found. Analysis 
of inpatient mental health service use indicated that the assumption of sphericity was violated, 
necessitating the Huynh-Feldt correction (ϵ = .746; F(1.49, 219.18) = 8.06, p = .001). Outpatient 
mental health service use also decreased significantly. Again, the Huynh-Feldt correction was 
used to correct the violation of sphericity (ϵ = .851). The results support a significant effect on 
service use across follow-up points, F(1.70, 267.22) = 19.05, p = .0001. Finally, emergency 
department mental health services also decreased significantly across follow-up points using the 
same correction for sphericity (ϵ = .954), F (1.90, 278.59) = 3.09, p = .05. 
Substance Use Service Use. Inpatient substance use service utilization declined across all three 
points. The assumption of sphericity was not met in analysis of inpatient substance use service 
utilization. The Greenhouse-Geisser correction was used (ϵ = .72). The findings indicate a 
significant effect on inpatient service use across follow-up points F(1.44, 208.71) = 4.68, p = 
.019. Outpatient service use increased significantly at the 6-month follow-up and declined, 
although not to baseline levels, at the 1-year follow-up. The Huynh-Feldt correction was used to 
correct the violation of sphericity (ϵ = .916). An effect was again found across follow-up 
points F(1.83, 272.95) = 10.53, p = .0001. There were not enough reported substance use 
emergency department visits at any point to allow for meaningful analysis. 
Substance Use 
The frequency of substance use and relapse rates were reduced at both 6 and 12 months 
following enrollment in the program. For participants who reported illegal drug use at baseline, 
relapse rates were 35% 6 months and 28% 12 months later. The majority (56%) of participants 
who were using illegal drugs at baseline were abstinent from illegal drug use at both 6 and 12 
months. Positive outcome trends were similar across all major substance use categories. 
Repeated measures ANOVA was conducted to further analyze the data using the variables 
number of days in the past 30 days using alcohol to intoxication and the number of days using 
various drugs in the past 30 days. 
Alcohol Use. Mauchly's test indicated that the assumption of sphericity had been violated, χ2(2) = 
125.44, p > .05; therefore degrees of freedom were corrected using the Huynh-Feldt estimates of 
sphericity (ϵ = .761). The findings indicate a significant difference in alcohol use to intoxication 
across follow-up points, F(1.52, 497.5) = 57.31, p < .01. Means for baseline and 6 and 12 months 
are displayed in Table 5. 
Table 5. Drug Use Outcomes 
  Baseline 6 Months 12 Months ANOVA   
Outcome Measure M SD M SD M SD F p N 
Alcohol use 7.55 10.27 2.77 6.88 2.55 6.67 57.74 a .0001 328 
Alcohol use > 4 5.91 9.51 1.54 5.4 1.43 5.09 57.31 b .0001 328 
Marijuana use 4.1 8.7 0.89 3.65 1.44 5.58 30.27 b .0001 327 
Cocaine use 5.6 9.18 1.34 4.85 1.8 5.46 50.26 b .0001 327 
Illegal drug use 9.51 11.15 2.26 6.01 2.85 7.21 94.30 b .0001 328 
Note. 328 participants completed the GPRA at all three follow-up points. aHunyh-Feldt 
correction; bGreenhouse-Geisser correction. 
To further understand the data across the follow-up points, a paired samples t-test was run using 
the 6- and 12-month follow-up points and baseline and 6-month follow-up points. Change was 
significant from baseline to 6 months (t(480) = 9.27, p = .0001). Significant change was not 
found, however (t(327) = .582, p > .05) for the 6- to 12-month analysis. 
Illegal Drug Use. Very few participants used drugs other than marijuana or cocaine, and these 
drugs, along with a composite of all illegal drugs, are the only ones analyzed in this study. Means 
for each follow-up point for these three variables are displayed in Table 5. Again, the assumption 
of sphericity was violated, χ2(2) = 67.89, p > .05, necessitating the Huynh-Feldt correction to 
degrees of freedom (ϵ = .846). A significant difference was found in illegal drug use across the 
three follow-up points as well,F(1.69, 553.02) = 94.30, p < .01. When cocaine and marijuana 
were examined separately, similar reductions were found. Cocaine use dropped significantly 
(F(1.65, 538.75) = 50.25, p < .01), as well marijuana use (F(1.62, 532.04) = 30.27, p < .01). 
Drug-Related Problems. Three measures of drug-related harm were collected that provided a 4-
point Likert scale response to the questions of whether the respondent experienced drug-related 
stress, changed activities due to drug use, and had emotional problems due to use. The 
Friedman's two-way analysis by ranks test was used to determine differences in these variables 
across follow-up points. Drug-related stress was reduced significantly across follow-up points 
(based on the Friedman's test χ2(2) = 117.41, p = .0001). Reduction in activity due to drug use 
also was reduced significantly (χ2(2) = 155.8, p = .0001) as were emotional problems due to drug 
use (χ2(2) = 141.31, p = .0001). Table 6 summarizes change in these variables across follow-up 
points. 
Table 6. Drug Use-Related Harms 
  Baseline 6 Months 12 
Months 
Friedman   
Outcome Measure M SD M SD M SD x 2 p N 
Drug use-related stress 2.87 1.22 1.87 1.17 1.79 1.17 117.41 .0001 263 
Reduced activity due to drug use 2.76 1.28 1.51 1.0 1.58 1.06 155.80 .0001 263 
Emotional problems due to drug 
use 
2.84 1.63 1.69 1.1 1.63 1.08 141.31 .0001 263 
Note. 263 participants completed these items at all three follow-up points. 
As seen in Table 6, the significant reduction in drug-related harm occurred from baseline to 
follow-up. To further describe this difference, a Wilcoxon signed-rank test was used because the 
data are ordinal and related samples are being compared. The drug-related stress from baseline to 
6 months z score was −10.36 (p = .0001), and from 6 months to 12 months the z score was −0.82 
(p > .05), indicating that a change in drug-related stress took place in the first 6 months of service 
receipt and that these changes were maintained from the 6-month to 12-month follow-up. The 
remaining drug-related harm variables, reduction in activity (baseline to 6 months, z = 12.82, p = 
.0001; 6 months to 12 months, z = −0.96, p = .339) and emotional problems due to drug use 
(baseline to 6 months, z = 11.63, p = .0001; 6 months to 12 months, z = −0.54, p = .59), followed 
a similar pattern. Drug use–related harm dropped significantly from the baseline to 6 months 
follow-up period, while only modest reductions took place from 6 to 12 months for all three 
variables. 
DISCUSSION 
The results of this research provide additional support for the application of the ACT model for 
use with individuals with co-occurring mental health and substance abuse disorders, and these 
results may be useful in improving substance abuse treatment for these individuals. Specifically, 
and consistent with previous findings (Drake, McHugo et al., 1998; Essock et al., 2006;Young et 
al., 2009), data from the project indicate that those participating in this integrated treatment 
model showed statistically significant improvements in substance abuse and mental health 
symptoms at 6-month follow-up, and it appears that continued service use may have contributed 
to these gains. 
While these gains in and of themselves are important, from a service delivery perspective the 
model is also likely an important tool in containing costs. Consistent with cost-effectiveness 
research on ACT, the results clearly demonstrated that individuals who participated in the project 
experienced statistically significant decreases in inpatient mental health and inpatient substance 
use service use (Latimer, 1999), typically the most expensive mode of service delivery. 
Additionally, outpatient substance abuse treatment and mental health outpatient treatment both 
rose at the 6-month follow-up interview but dropped at the 12-month follow-up interview. This 
could be seen as a cost-saving measure as consumers are utilizing outpatient treatments as 
opposed inpatient, which in this study dropped steadily in both mental health and substance 
abuse treatment. Additionally, emergency department visits for mental health crises (also 
typically expensive) decreased at statistically significant rates. Consistent with previous findings 
on ACT, individuals in the project also enjoyed higher levels of permanent housing and lower 
levels of homelessness (Essock et al., 1998; Nelson, Aubry, & Lafrance, 2007). 
The generalizability of the findings from this evaluation is limited, and the results from this study 
are only truly applicable to the individuals who participated in the evaluation. As a 
nonexperimental design without a randomized control group of individuals who did not 
experience the intervention, these findings are only suggestive of the possibility that these results 
are due to the participants’ involvement in the program, although they are highly suggestive of 
this idea due to the significance of the change found in the group. Clearly, programs of this type 
need to be further evaluated through a study with a more rigorous design. 
Another limitation of this study is the lack of fidelity measures to ensure there is not drift from 
the original intervention (Bond, Drake, Mueser, & Latimer, 2001; Siskind & Wiley-Exley, 
2009). Within the program, supervision was provided to staff on a regular basis to ensure 
fidelity, but no measure of this is available. This was recognized as a problem in this study and in 
a subsequent grant supporting the implementation of a similar I-ACT intervention in Memphis, 
Tennessee, the Dartmouth Assertive Community Treatment Scale. 
Additionally, research based on this type of sampling runs the risk of sampling bias, as those 
individuals who were in the sample may not accurately represent the pool of potential service 
recipients. For example, in the current study, the number of participants who provided baseline 
and 6- and 12-month follow-up data (n = 313) represent 63% of the total number of service 
recipients. To control for this, analyses were run comparing baseline demographics and outcome 
data, which indicated that the only significant difference in those who completed baseline only to 
those that had follow-up interviews was a higher percentage of drug-dependent and -abusing 
individuals. Surprisingly, participants with diagnosed drug dependence or abuse using the TAAD 
were more likely to complete the follow-up interviews. While this analysis indicates equality of 
groups and higher severity of drug use among those maintained in the study, results should still 
be viewed tentatively due to the difficulties with follow-up. 
Despite all of these limitations, the results of this evaluation do remain important. Consistent 
with other studies using an ACT treatment model with consumers with co-occurring disorders 
(Drake, McHugo, et al., 1998; Essock et al., 2006), several of the major outcome measures 
showed significant improvements, including alcohol and drug use, psychiatric symptom severity, 
and housing stability. These results can be utilized to develop and/or enhance the services to 
similar individuals in other areas. The project clearly demonstrated the positive impact the 
combined I-ACT intervention had on mental health, substance abuse, and service use, making it 
an important intervention for service providers to employ. The fact that this was done in a cost-
reducing manner that improved community stability only enhances the idea that this intervention 
should be more readily utilized for similar populations of individuals with co-occurring 
disorders. This is a population that has been historically described as hard to reach and/or 
noncompliant with traditional models of service delivery. The simple fact that individuals 
engaged with these services at a high rate cannot by itself be understated. Clearly, further study 
using randomized control designs and comparison groups are needed to further support the 
adoption of the I-ACT intervention. 
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